Single Anastomosis Sleeve Jejunal (SAS-J) Bypass

Not Applicable

Completed

• Conditions: Morbid Obesity
• Interventions: Procedure: Single Anastomosis Sleeve Jejunal (SAS-J) Bypass

• Registration Number: NCT02870530
• Lead Sponsor: Minia University

Brief Summary

The purpose of this study is to determine the efficacy of single anastomoses sleeve jejunal bypass as a treatment for morbid obesity

Detailed Description

in this study the investigators aim to test a new technique ( single anastomoses sleeve jejunal as a treatment for morbid obesity Which is a modification of Single anastomoses sleeve ileal bypass with short biliary limb ( about one third of the small intestine from the Duodeno-jejunal junction

Study Timeline

• Study First Submitted: 2016-08-10
• Study First Submitted QC: 2016-08-12
• Study First Posted: 2016-08-17
• Study Start: 2016-11
• Primary Completion: 2017-04
• Study Completion: 2017-04
• Status Verified: 2022-02
• Last Update Submitted: 2022-02-25
• Last Update Posted: 2022-03-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• obese patients with BMI more than 40
• patients fit for laparoscopic surgery
• give approval to share in the study

Exclusion Criteria

• patients refused to share in the study
• patients unfit for surgery
• patients aged less than 18 and older than 50
• patients with BMI less than 50
• patient with previous upper abdominal surgery either for obesity or other diseases
• patients with preoperative GERD clinically or by investigation

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Single Anastomosis Sleeve Jejunal (SAS-J) Bypass	Single Anastomosis Sleeve Jejunal (SAS-J) Bypass	Single Anastomosis Sleeve Jejunal (SAS-J) Bypass as A treatment for Morbid

Primary Outcome Measures

Name	Time	Method
intraoperative complications	the 1st 24 hours	intraoperative complications like bleeding, other organs injuries
the postoperative weight loss	12 month	the percentage of weight loss from total excess body weight
operative time	the 1st 24 hours	the operative time from skin incision to skin closure

Secondary Outcome Measures

Name	Time	Method
effect on metabolic syndrome if present	12 months	effect on blood sugar level, blood pressure and blood cholesterol level

Trial Locations

Locations (1)

Minia university hospital; 🇪🇬 Minya, Egypt